AR083366A1 - Formulaciones para el tratamiento de las afecciones de las vias aereas superiores - Google Patents

Formulaciones para el tratamiento de las afecciones de las vias aereas superiores

Info

Publication number
AR083366A1
AR083366A1 ARP110103733A ARP110103733A AR083366A1 AR 083366 A1 AR083366 A1 AR 083366A1 AR P110103733 A ARP110103733 A AR P110103733A AR P110103733 A ARP110103733 A AR P110103733A AR 083366 A1 AR083366 A1 AR 083366A1
Authority
AR
Argentina
Prior art keywords
formulations
treatment
affection
airways
useful
Prior art date
Application number
ARP110103733A
Other languages
English (en)
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of AR083366A1 publication Critical patent/AR083366A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se refiere a formulaciones que comprenden extractos de Vaccinium myrtillus o de otras especies ricas en antocianósidos, de Punica granatum, de Echínacea, y eventualmente de Kramería triandra. Estas formulaciones son útiles en el tratamiento de afecciones de la boca y sus anexos, de la garganta y del aparato respiratorio y en el tratamiento de la gripe. De manera particular, las incorporadas a vehículos apropiados son particularmente útiles en las infecciones bacterianas y virales de la primera infancia.
ARP110103733A 2010-10-11 2011-10-11 Formulaciones para el tratamiento de las afecciones de las vias aereas superiores AR083366A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2010A001852A IT1402018B1 (it) 2010-10-11 2010-10-11 Formulazioni per il trattamento delle affezioni delle prime vie respiratorie.

Publications (1)

Publication Number Publication Date
AR083366A1 true AR083366A1 (es) 2013-02-21

Family

ID=43737984

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110103733A AR083366A1 (es) 2010-10-11 2011-10-11 Formulaciones para el tratamiento de las afecciones de las vias aereas superiores

Country Status (21)

Country Link
US (1) US9168276B2 (es)
EP (1) EP2627345B1 (es)
JP (2) JP6250397B2 (es)
KR (1) KR101870979B1 (es)
CN (1) CN103189065B (es)
AR (1) AR083366A1 (es)
AU (1) AU2011315708B2 (es)
BR (1) BR112013008771B1 (es)
CA (1) CA2814312C (es)
DK (1) DK2627345T3 (es)
ES (1) ES2496892T3 (es)
HK (1) HK1186671A1 (es)
IL (1) IL225668A (es)
IT (1) IT1402018B1 (es)
MX (1) MX342986B (es)
PL (1) PL2627345T3 (es)
PT (1) PT2627345E (es)
RU (1) RU2580643C2 (es)
SG (1) SG189345A1 (es)
SI (1) SI2627345T1 (es)
WO (1) WO2012049045A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6075526B2 (ja) * 2012-07-04 2017-02-08 アサヒビール株式会社 ビール又はビール様飲料及びその製造方法
EP2908834B1 (en) * 2012-10-17 2017-07-12 Montero Gida Sanayi Ve Ticaret A.S. New formulations comprising plant extracts
CN104304548A (zh) * 2014-10-27 2015-01-28 陈国勇 一种预防感冒茶及其制备方法
EP3103465A1 (en) 2015-06-10 2016-12-14 Raman Mehta Formulations for the treatment of mucosal lesions
EP3103464A1 (en) 2015-06-10 2016-12-14 Raman Mehta Formulations for the treatment of disorders of the mouth, throat and respiratory tract
JP2018528977A (ja) 2015-09-22 2018-10-04 バイタリティ バイオファーマ インコーポレイテッドＶｉｔａｌｉｔｙ Ｂｉｏｐｈａｒｍａ， Ｉｎｃ． カンナビノイドグリコシドプロドラッグおよび合成の方法
ITUA20161822A1 (it) * 2016-03-18 2017-09-18 Indena Spa Composizioni utili nella prevenzione e/o nel trattamento di patologie del cavo orale, delle prime vie aeree e dell’esofago
EP3634390B1 (en) * 2017-05-09 2023-09-27 Graphium Biosciences, Inc. Antimicrobial compositions comprising cbd or thc against c. difficile infection or e. faecalis
EP3946404A1 (en) * 2019-03-29 2022-02-09 Evonik Operations GmbH Preparations containing berry extracts for use in the prophylaxis and/or treatment of viral infections caused by paramyxoviridae
WO2020201055A1 (en) * 2019-03-29 2020-10-08 Evonik Operations Gmbh Preparations containing berry extracts for use in the prophylaxis and/or treatment of viral infections caused by pneumoviridae
AU2020252112A1 (en) * 2019-03-29 2021-11-25 Evonik Operations Gmbh Combined preparation comprising an anthocyanin composition and an antiviral agent
KR102232733B1 (ko) * 2019-04-16 2021-03-26 주식회사 파미니티 에키네시아 추출물을 포함하는 항바이러스용 조성물
IT201900024997A1 (it) * 2019-12-20 2021-06-20 Dymalife Res S R L Associazione per uso nel trattamento e/o prevenzione degli stati influenzali e delle affezioni delle alte vie respiratorie
IT202000018949A1 (it) 2020-08-03 2022-02-03 Arterra Bioscience S P A Estratto derivato da bucce di punica granatum per la prevenzione e il trattamento di infezioni virali

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07106972B2 (ja) * 1987-04-24 1995-11-15 佐藤製薬株式会社 歯科口腔用薬剤
EP1049480B1 (en) * 1998-01-30 2002-09-11 Rhinopharma AS Herbal anti-viral agent
JP2000136141A (ja) * 1998-10-30 2000-05-16 Sumitomo Forestry Co Ltd 抗菌剤
US6241975B1 (en) * 1999-07-24 2001-06-05 Pacific Corporation Method for preparation of plant extract powder
JP2001122795A (ja) * 1999-10-27 2001-05-08 Nissui Pharm Co Ltd 感染性疾患予防・治療剤
IL143318A0 (en) * 2001-05-23 2002-04-21 Herbal Synthesis Corp Herbal compositions for the treatment of mucosal lesions
CN1164299C (zh) * 2001-09-07 2004-09-01 张印昌 治疗急慢性炎症的中药制剂克炎口服液及制作方法
JP2003113013A (ja) * 2001-09-28 2003-04-18 Lion Corp 植物性抗菌防腐剤
JP4444593B2 (ja) * 2003-08-21 2010-03-31 日本メナード化粧品株式会社 抗菌剤
ITMI20032287A1 (it) 2003-11-24 2005-05-25 Indena Spa Composizioni per il trattamento delle affezioni del cavo orale e delle prime vie respiratorie
ITMI20042414A1 (it) 2004-12-17 2005-03-17 Indena Spa Formulazione per il trattamento di affezioni delle prime vie respiratorie
US20080057143A1 (en) 2006-06-01 2008-03-06 Mohammad Madjid Method of using composition comprising pomegranate extracts against influenza
CN101057953A (zh) * 2006-04-21 2007-10-24 陈祖辉 对付病毒感染疾患的多靶协同防治制剂
WO2007133721A2 (en) * 2006-05-12 2007-11-22 Interleukin Genetics, Inc. Food compositions and methods of treating periodontal disease
US7820207B2 (en) * 2007-03-15 2010-10-26 Omnica Gmbh Stabilized anthocyanin compositions
US20090035226A1 (en) * 2007-07-31 2009-02-05 Phenolics, Llc Use of cranberry extract enriched in total phenols and free, essentially free, or substantially free of sugars, acids, sulfur and other contaminants, for periodontal treatment
US8496975B2 (en) 2008-04-24 2013-07-30 Indena S.P.A. Compositions for the treatment and prevention of infections of the oral cavity
US20090304826A1 (en) * 2008-05-30 2009-12-10 Fairfield Clinical Trials, Llc Method and composition for dermatoses
ES2393239T3 (es) * 2008-06-05 2012-12-19 Indena S.P.A. Composiciones para el tratamiento de trastornos del tracto respiratorio superior y síndromes de infuenza

Also Published As

Publication number Publication date
ITMI20101852A1 (it) 2012-04-12
IT1402018B1 (it) 2013-08-28
IL225668A (en) 2016-12-29
IL225668A0 (en) 2013-06-27
CN103189065A (zh) 2013-07-03
CN103189065B (zh) 2015-03-18
CA2814312A1 (en) 2012-04-19
WO2012049045A1 (en) 2012-04-19
CA2814312C (en) 2021-10-12
SG189345A1 (en) 2013-05-31
AU2011315708A1 (en) 2013-04-18
KR20130142115A (ko) 2013-12-27
DK2627345T3 (da) 2014-09-01
BR112013008771A2 (pt) 2021-04-20
ES2496892T3 (es) 2014-09-22
US20130280355A1 (en) 2013-10-24
BR112013008771B1 (pt) 2022-02-22
US9168276B2 (en) 2015-10-27
JP2016155878A (ja) 2016-09-01
PL2627345T3 (pl) 2015-01-30
EP2627345B1 (en) 2014-07-23
JP2013539770A (ja) 2013-10-28
JP6250397B2 (ja) 2017-12-20
MX2013004008A (es) 2013-04-24
EP2627345A1 (en) 2013-08-21
RU2013121576A (ru) 2014-11-20
SI2627345T1 (sl) 2014-10-30
AU2011315708B2 (en) 2014-03-20
KR101870979B1 (ko) 2018-06-25
RU2580643C2 (ru) 2016-04-10
HK1186671A1 (en) 2014-03-21
PT2627345E (pt) 2014-09-04
MX342986B (es) 2016-10-19

Similar Documents

Publication Publication Date Title
AR083366A1 (es) Formulaciones para el tratamiento de las afecciones de las vias aereas superiores
MX341395B (es) Compuestos (lipopeptidos basados en cisteina) y composiciones como agonistas de tlr2 usados para el tratamiento de infecciones, inflamaciones, enfermedades respiratorias, etc.
BRPI1002601E2 (pt) composição nanoestruturada de uso veterinário para administração de fármacos
MD4577B1 (ro) Compoziţii masticabile de uz veterinar care conţin agent activ izoxazolinic şi utilizarea acestora în tratamentul sau prevenirea unei infestări sau infecţii parazitare
BR112014024159A2 (pt) Formulações de vacina oral específicas do local gastrintestinal , ativas no íleo e apêndice.
BR112015016930A2 (pt) formulações farmacêuticas estabilizadas de análogos de insulina e/ou derivados de insulina
SV2010003581A (es) 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso
AR081681A1 (es) METODOS Y COMPOSICIONES PARA LA ADMINISTRACION INTRATECAL DE b-GALACTOCEREBROSIDASA
CU20120148A7 (es) Metodos y composiciones para el suministro intranasal
CL2017003066A1 (es) Composiciones de carbonato de calcio amorfo para administración mediante inhalación, sublingual o bucal
AR091465A1 (es) Una composicion farmaceutica que contiene acido nicotinico y/o nicotinamida y/o triptofano para influenciar positivamente la microbiota intestinal
CL2012001836A1 (es) Compuestos de pirazol, antagonista de crth2; composicion farmacéutica; uso en el tratamiento de trastornos inflamatorios, infecciosos, inmunoreguladores, enfermedades respiratorias, gastrointestinales o dolencias, entre otros.
UY32457A (es) Vacuna del virus del dengue inactivado
UY29395A1 (es) Formulación de medicamentos conteniendo vardenafilo.
PT2575873E (pt) Concentração de antigénios de vacinas com liofilização
AR092897A1 (es) Composiciones inmunogenicas
AP2014008162A0 (en) Pharmaceutical composition for treatment of the pulmonary form of altitude sickness caused by lack of oxygen and reduced air pressure
AR096854A1 (es) Composición farmacéutica para una liberación sostenida de lanreotide
BR112015030431A2 (pt) formulação de liberação modificada
BR112012030619A2 (pt) concentração de antígenos de vacina influenza sem liofilização.
BR112012015449A2 (pt) suspensão de monoidrato de calcipotriol, monoidrato de calcipotriol, processo para preparar nanocristais de monoidrato de calcipotriol, e, composição farmacêutica
CL2017000884A1 (es) Composición farmacéutica para usarse en el tratamiento o la prevención de deficiencias de vitaminas y minerales en pacientes que han sido sometidos a cirugía de derivación gástrica
BRPI1012077A2 (pt) combinação de uma fonte de leucina e uma fonte de ácido graxo, e, composição nutricional, uma composição farmacêutica ou uma composição nutracêutica
CL2010001594A1 (es) Uso de nifurtimox para preparar un medicamento útil en el tratamiento de enfermedades causadas por trichomonadida.
MX2016005720A (es) Composiciones y metodos para administracion de una enzima a las vias respiratorias de un sujeto.

Legal Events

Date Code Title Description
FC Refusal